Blue Horseshoe Stocks

Blue Horseshoe Stocks: NIHD Review & More

NII Holdings, Inc. NIHD

We initially tagged NIHD in our premarket report from last Thursday, and on that day we would observe a low of .5472 in the stock. It’s been stepping its way up, but this morning in premarket trading things have really kicked into high gear, with NIHD cracking through the dollar barrier.

As of this morning’s premarket high of 1.14, we’ve now witnessed an increase of 108% in NIHD over a span of just three trading sessions. In order for us to remain highly interested in this play, we’ll want to see it maintain support at or above its current 50DMA of .83 on any pullbacks that may occur.

Celsion Corp. CLSN

We called out CLSN in yesterday morning’s premarket report, and saw a modest yet respectable move out of that play as well. From a low of 3.85 the stock ran as high as 4.96, marking an intraday move of 29%

The stock was number four on the NASDAQ’s top gainer list for the day, and while it did end up tapering back to close near its daily lows, this morning it is gapping up again in the premarket. This surge of activity is primarily due to yesterday’s announcement of positive results in its ovarian cancer treatment trials.

We’ll definitely be keeping CLSN on our radars and watching for the continued establishment of higher lows off of our recently observed bottom.

Bitcoin Services, Inc. BTSC

BTSC was a part of the bitcoin watchlist we issued on May 25th in the midst of a bitcoin frenzy where the crypto-currency was soaring to new all-time highs.

The residual effect for plays like BTSC has been impressive, with with stocks PPS making a jump from our observed low of .0366 up to a new high of .164 yesterday, which represents a 348% rip which occurred over a period of just seven sessions.

Egalet Corp. EGLT

Not only is EGLT coming off of a bottom on the chart, but in the space of the past 36 hours, the company has made two major announcements.

Yesterday, it was made known that EGLT had “received a U.S. patent for its proprietary Guardian™ Technology tablet architecture used to create precise delivery of combination products with immediate-, delayed- and/or extended-release properties.” (>>View PR)

Today, the announcement was that “one of the largest payers in the United States will provide coverage of ARYMO® ER (morphine sulfate) extended-release tablets” (>>View PR)

Extended Watchlist:
KMI, GAHC, EBIO, GALT, IAG, BLDP, SBGL

Blue Horseshoe Stocks: CNXS Recap & More

Connexus Corp. CNXS

After initially tagging CNXS on Thursday May 25th amid a major spike of bitcoin hysteria, we witnessed a low of .0007 in the stock, and in the six sessions that have followed it has been building up quite a head of steam.

From that initial observed low, CNXS has gone on to hit a high of .003. which represents a very nice move of 329% while volume over this recent period has been heightened considerably.

We’ve been noticing a few other newsletters finally catching on, but to our knowledge we were the first to the party on CNXS. We’ll continue to monitor its progress moving forward, and will remain interested provided it holds support at or above a previous area of resistance at .0018 on any pullbacks.

FitBit, Inc. FIT – Options Idea

After sitting on the sidelines for many months on FIT, and watching the stock get crushed, we’ve seen it beginning to come up off of its recently established 52-week lows and are beginning to see it as a potential value play.

If our inkling is correct, a play of FIT stock itself would likely work out rather well over the longer term, but as our readers are aware, we like to try to score big with options plays when an opportunity presents itself.

In this case, we’d like to signal a range of extended-term contracts with an August expiration, namely, the FIT 08/18 $5-7 Calls. This will give us plenty of time for FIT to restablish itself and hopefully mount the recovery that appears possible given the current look of the chart.

Celsion Corp. CLSN

Speaking of bottom plays, we’re noticing that CLSN has recently registered a new annual low on Wednesday, and has been attempting to gain some traction and come up off of that bottom.

With the stock very close to extreme oversold territory, we’ll want to place it on watch as a possible rebound play.

Extended Watchlist:
DVAX, HMNY, PERI, RFP, EXTR, FOR

Blue Horseshoe Stocks: Options, Bottom-Plays & More

Dollar General Corp. DG – Recap

After a beat on sales and profits for the quarter and a chart primed for a bullish move, we highlighted the DG Weekly $75-78 Calls and we’re happy to report that each and every one of the contracts contained within that range recorded huge intraday moves for us.

Regardless which set of the seven was chosen, multi-bag gains were there for the taking:

$75 Calls – Range: .92-3.10 – Max Gain: 237%
$75.50 Calls – Range: .64-.2.22 – Max Gain: 247%
$76 Calls – Range: .40-2.05 – Max Gain: 412%
$76.50 Calls – Range: .24-1.20 – Max Gain: 400%
$77 Calls – Range: .12-1.21 – Max Gain: 908%
$77.50 Calls – Range: .06-.80 – Max Gain: 1233%
$78 Calls – Range: .05-.45 – Max Gain: 800%

_______

Lululemon Athletica LULU – Fresh Ideas

Lululemon had an earnings beat of its own yesterday post-market, so we want to formulate some ideas for the LULU chain as well.

Not only is the stock gapping up on earnings, but like DG yesterday, the LULU chart was already looking like a bottom-play with premium potential. That’s why we want to formulate both a short and long term set of ideas for LULU options. The LULU Weekly $55-57.50 Calls*, to coincide with the immediate boost in activity off of these earnings, and the LULU 06/30 58.50-60.50 Calls in the event of a protracted recovery.

*We never highlight options with a weekly expiration on a Friday without an explicit warning. That should tell you how risky it can be. So if you’re not an expert trader, don’t even think about it!

Synergy Pharmaceuticals, Inc. SGYP

We also want to put SGYP on watch today after noticing that the stock is coming off of its 52-week lows. That’s always a chart setup that we’re going to look at, but in this case the lows followed shartly after the company producing positive Phase III data on its TRULANCE™ drug, which is already approved by the FDA.

We’ve included a chart snapshot here, and you can plainly see, the stock had been beaten back severely and is only just now beginning to mount a rebound.

Extended Watchlist:
DOLV, USRM, ICNB, ANW, CGG, ANTH

Blue Horseshoe Stocks: GYST Video, Other Updates

The Graystone Company GYST

Our first order of business this morning is to provide an update on GYST, which was the subject of our special report yesterday. If you did not catch our report, you can do so by hitting the following link >>GYST REPORT

To illustrate GYST’s performance during yesterday’s session, what better way to go over it than a video chart from our very own Stock Sumo! Click through to the video below, and also receive a quick lesson in understanding Level 2 quotes, which is vital for any beginning trader to take the next step!

>>GYST Video

The dip-and-rip we saw in GYST from .007 to .012 represented an intraday upswing of 71%, so, a very good first day of observation. As Stock Sumo was mentioning, we want to see GYST hold support at or above the channel between .0064-.007 on any pullbacks, and will look for an eventual break of resistance at .0125.

OTHER UPDATES:

Viva Entertainment Group, Inc. OTTV -We tagged OTTV in Friday’s extended watchlist and we wanted to circle back this morning to mention the solid activity that followed from this stock over subsequent sessions.

On Friday, we observed a low of .0004 and witnessed a pretty nice 75% rip to .0007. As of yesterday, OTTV had extended its high to .001, and boosted our three-session observed upswing on the stock to a nice, round 150%
_____

Pilgrim Petroleum Corp. PGPM – For another quick update, we’ve witnessed a pretty good two-day swing in PGPM after alerting it in Tuesday’s premarket report, and observing a low of .011. Yesterday, the stock hit .0183, which was good for a respectable overall move of 66%

Dollar General Corp. DG

We want to leave off this morning with an earnings-related options idea. We’ve had a ton of success this earnings season, and will try to keep that going with Dollar General.

Not only did the company reveal a beat on sales and profits for the quarter, but the current chart setup was already primed for a bullish move. We’ll be putting the DG Weekly $75-78 Calls on watch for potential day and/or swing trades.

Extended Watchlist:
SPI, MNKD, PLX, DXTR, CYTX, NIHD

Blue Horseshoe Stocks Special Report

Special Report: The Graystone Company GYST

The focus of this special report to kick off the holiday-shortened week is GYST, which is a company with active operations in both the mining and cannabis industries. As our regular readers can attest, those are two market spaces that we have been very fond of in the past, but to find one company with its hands in both is an interesting change of pace.

The company has been actively engaging its shareholders on both fronts as well, recently issuing key updates, but before we jump into that, we also want to point out the massive share restructuring GYST announced this month, in which it immediately effected a 95% reduction in its authorized shares, reducing the count to 500M. (>>View PR)

______

GYST CANNABIS OPERATIONS:

As we hinted at above, GYST building out a scalable business operation in the cannabis industry that includes multiple California-based cannabis delivery services and dispensaries. The initial delivery service began operations in March 2017 and has rapidly expanded into multiple target markets with plans for aggressive expansion for the remainder of 2017.

Per a recent update, the revenue intake and expansion of its cannabis operations has been even more aggressive than the company itself expected, which is an exciting prospect. California only recently legalized the sale of recreational marijuana, but its medical programs and cannabis counter-culture has been thriving for decades, beginning in 1996 with Proposition 215 (The Compassionate Use Act).

The CEO of GYST, M.T. Soeparmo stated, “Our company is growing at a rapid pace … we are projecting 20K to 25K in revenue for the month of May and based on current trends, that number should surpass 30K as early as June. The scalability of our business has allowed us to expand our reach well beyond our original target markets. In fact, plans for additional expansion are well under way.” (>>View Full PR)

More recently, Soeparmo mentioned that more updates on GYST’s cannabis operations are forthcoming, so we’ll definitely want to keep an eye peeled for that.
______

GYST MINING OPERATIONS:

With the cannabis aspects of its business clearly gaining traction faster than the company expected, GYST management reminded shareholders last week not to forget the promising mining operations it is currently carrying out in South America.

According to Graystone, its mining operations focus primarily on acquiring properties that require a lower capital investment to begin mining operations. This approach may reduce the size of the deposits that the company can produce, however, by generating revenue from smaller mining ventures, the company can build a solid foundation and the needed infrastructure to undertake larger ventures such as hard rock projects in the future.

M.T. Soeparmo, CEO, said, “Our current mining operation is located in Suriname and is a 160-acre site. With only 12 acres of that being mined currently, the operation has already achieved break even status. 148 acres is still yet to be mined actively so we estimate a five to seven year life span on the current 12 acres and tested locations with other locations currently being scouted.

Mr. Soeparmo finished up with, “We could not be more pleased with our current business operations. The cannabis business has exploded in a very short time frame and our mining operations provide a sizable long term contribution to our revenue goals. We look forward to sharing more information with investors in the coming weeks including an up to date website that outlines our current business operations, recent press and financials.” (>>View PR)

______

GYST CHART :

Lastly, we want to take a look at the current setup of the GYST chart.

A return to the 52-week high of .0215 from current PPS levels could make for gains of more than 80% Presently, the RSI is not overbought by any means, and appears rather bullish, being above 50-line with the MACD showing a recent bullish cross!

As mentioned above, GYST is currently working on a new and updated website, so for now, you can begin your own due diligence on the company by starting at its page on OTC Markets (>>View GYST Page)